Integral Health Asset Management, LLC
Position in ELVN — Enliven Therapeutics, Inc.
CIK 1773206
New York, NY
Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,612,500
New position
Shares Held
150,000
first reported quarter
Ownership
0.205%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#67
of 210 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Integral Health Asset Management, LLC holds $1,502,601,600 across 54 Biotechnology names. ELVN ranks #34 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,500,000 | $280,920,000 | |
| 2 | INSM |
INSMED Inc
|
1,600,000 | $170,592,000 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,600,000 | $136,304,000 | |
| 4 | EWTX |
Edgewise Therapeutics, Inc.
|
2,000,000 | $81,260,000 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
1,750,000 | $75,092,500 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
300,000 | $73,431,000 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,000,000 | $70,780,000 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
550,000 | $61,066,500 |
All Filings in ELVN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,612,500 | 150,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||